Middle East Respiratory Syndrome-Coronavirus Infection into Established hDPP4-Transgenic Mice Accelerates Lung Damage Via Activation of the Pro-Inflammatory Response and Pulmonary Fibrosis
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Middle East respiratory syndrome coronavirus (MERS-CoV) infects the lower respiratory airway of humans, leading to severe acute respiratory failure. Unlike human dipeptidyl peptidase 4 (hDPP4), a receptor for MERS-CoV, mouse DPP4 (mDPP4) failed to support MERS-CoV infection. Consequently, diverse transgenic mouse models expressing hDPP4 have been developed using diverse methods, although some models show no mortality and/or only transient and mild-to-moderate clinical signs following MERS-CoV infection. Additionally, overexpressed hDPP4 is associated with neurological complications and breeding difficulties in some transgenic mice, resulting in impeding further studies. Here, we generated stable hDPP4-transgenic mice that were sufficiently susceptible to MERS-CoV infection. The transgenic mice showed weight loss, decreased pulmonary function, and increased mortality with minimal perturbation of overexpressed hDPP4 after MERS-CoV infection. In addition, we observed histopathological signs indicative of progressive pulmonary fibrosis, including thickened alveolar septa, infiltration of inflammatory monocytes, and macrophage polarization as well as elevated expression of profibrotic molecules and acute inflammatory response in the lung of MERS-CoV-infected hDPP4-transgenic mice. Collectively, we suggest that this hDPP4-transgenic mouse is useful in understanding the pathogenesis of MERS-CoV infection and for antiviral research and vaccine development against the virus.
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) infects the lower respiratory airway of humans, leading to severe acute respiratory failure. Unlike human dipeptidyl peptidase 4 (hDPP4), a receptor for MERS-CoV, mouse DPP4 (mDPP4) failed to support MERS-CoV infection. Consequently, diverse transgenic mouse models expressing hDPP4 have been developed using diverse methods, although some models show no mortality and/or only transient and mild-to-moderate clinical signs following MERS-CoV infection. Additionally, overexpressed hDPP4 is associated with neurological complications and breeding difficulties in some transgenic mice, resulting in impeding further studies. Here, we generated stable hDPP4-transgenic mice that were sufficiently susceptible to MERS-CoV infection. The transgenic mice showed weight loss, decreased pulmonary function, and increased mortality with minimal perturbation of overexpressed hDPP4 after MERS-CoV infection. In addition, we observed histopathological signs indicative of progressive pulmonary fibrosis, including thickened alveolar septa, infiltration of inflammatory monocytes, and macrophage polarization as well as elevated expression of profibrotic molecules and acute inflammatory response in the lung of MERS-CoV-infected hDPP4-transgenic mice. Collectively, we suggest that this hDPP4-transgenic mouse is useful in understanding the pathogenesis of MERS-CoV infection and for antiviral research and vaccine development against the virus.
참고문헌 (45)
- WHO MERS-CoV Research Group, "State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans", PLoS Curr, 5 (2013)
- 이정윤, "Generation of Full-Length Infectious cDNA Clones of Middle East Respiratory Syndrome Coronavirus", Journal of Microbiology and Biotechnology, 29(6), pp.999~1007 (2019), 한국미생물·생명공학회[DOI]
- Raj VS, "Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC", Nature, 495, pp.51~254 (2013)
- van Doremalen N, "Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4", J. Virol, 88, pp.220~9232 (2014)
- Boonacker E, "The multifunctional or moonlighting protein CD26", DPPIV, 2003, pp.82, 53~73
- Mackay IM, "Middle East respiratory syndrome : An emerging coronavirus infection tracked by the crowd", Virus Res, 202, pp.60~88 (2015)
- Coleman CM, "Wild type and innate immune deficient mice are not susceptible to the middle east respiratory syndrome coronavirus", J. Gen. Virol, 95, pp.408~412 (2013)
- Raj VS, "Aden-osine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus", J. Virol, 88, pp.1834~1838 (2014)
- de Wit E, "The Middle East respiratory syndrome coronavirus(MERS-CoV)does not replicate in Syrian hamsters", PLoS One, 8, pp.e69127~ (2013)
- Coleman CM, "Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus", J. Gen. Virol, 95, pp.408~412 (2014)
- Scobey T, "Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus", Proc. Natl. Acad. Sci. USA, 110, pp.16157~16162 (2013)
- Cockrell AS, "Mouse d ipeptidyl p ep tidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection", J. Virol, 88, pp.5195~5199 (2014)
- de Wit E, "Middle East respiratory syndrome coronavirus(MERS-CoV)causes transient lower respiratory tract infection in rhesus macaques", Proc. Natl. Acad. Sci. USA, 110, pp.16598~16603 (2013)
- Falzarano D, "Infection with MERS-CoV causes lethal pneumonia in the common marmoset", PLoS Pathog, 10, pp.e1004250~ (2014)
- Zhao J, "Rapid generation of a mouse model for Middle East respiratory syndrome", Proc. Natl. Acad. Sci. USA, 111, pp.4970~4975 (2014)
- Zhao G, "Multi-Organ damage in human dipeptidyl peptidase 4transgenic mice infected with Middle East respiratory syndrome-coronavirus", PLoS One, 10, pp.e0145561~ (2015)
- Agrawal AS, "Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease", J. Virol, 89, pp.3659~3670 (2015)
- Mu J, "Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes", Eur. J. Pharmacol, 623, pp.148~154 (2009)
- Tseng CT, "Apical entry and release of severe a cutere spiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells", J. Virol, 79, pp.9470~9479 (2005)
- Ohnuma K, "Revisiting an old acquaintance : CD26 and its molecular mechanisms in T cell function", Trends Immunol, 29, pp.295~301 (2008)
- Reed M, "Deficiency of autophagy protein Map1-LC3b mediates IL-17-dependent lung pathology during respiratory viral infection via ER stress-associated IL-1", Mucosal. Immunol, 8, pp.1118~1130 (2015)
- Wilson MS, "Pulmonary fibrosis: pathogenesis, etiology and regulation", Mucosal. Immunol., 2, pp.103~121 (2009)
- Wynn, T. A., "Cellular and molecular mechanisms of fibrosis", J. Pathol, 214, pp.199~210 (2008)
- Kim J, "Human β-defensin 2 is involved in CCR2-mediated Nod2 signal transduction, leading to activation of the innate immune response in macrophages", Immunobiology, 224, pp.502~510 (2019)
- Zhou J, "Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages : implications for pathogenesis", J. Infect. Dis, 209, pp.1331~1342 (2014)
- 이정윤, "Middle East Respiratory Syndrome Coronavirus-Encoded Accessory Proteins Impair MDA5-and TBK1-Mediated Activation of NF-κB", Journal of Microbiology and Biotechnology, 29(8), pp.1316~1323 (2019), 한국미생물·생명공학회[DOI]
- Kang Li, "Regulation of Cellular Antiviral Signaling by Modifications of Ubiquitin and Ubiquitin-like Molecules", Immune Network, 18(1), pp.1~20 (2018), 대한면역학회[DOI]
- Tseng CT, "Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor", J. Virol, 81, pp.1162~1173 (2007)
- Yoshikawa N, "Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2", J. Virol, 83, pp.5451~5465 (2009)
- Tilbury K, "Second harmonic generation microscopy analysis of extracellular matrix changes in human idiopathic pulmonary fibrosis", J. Biomed. Opt, 19, pp.086014~ (2014)
- Wong SL, "The SPARC protein an overview o f its role i n lung c ancer and p ulmonary f ibrosis and its potential role in chronic airways disease", Br. J. Pharmacol, 174, pp.3~14 (2017)
- Pardo A, "Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis", PLoS Med, 2, pp.e251~ (2005)
- Borthwick LA, "Cytokine mediated tissue fibrosis", Biochim. Biophys. Acta, 1832, pp.1049~1060 (2013)
- Pascal KE, "Pre-and postexposure effi-cacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection", Proc. Natl. Acad. Sci. USA, 112, pp.8738~8743 (2015)
- Cockrell AS, "A mouse model for MERS coronavirus induced acute respiratory distress syndrome", Nat. Microbiol, 2, pp.16226~ (2016)
- Li K, "Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4", J. Infect. Dis, 213, pp.712~722 (2016)
- Laksitorini M, "Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers", Ther. Deliv, 5, pp.1143~1163 (2014)
- Takasawa W, "Inhibition of dipeptidyl peptidase 4regulates microvascular endothelial growth induced by inflammatory cytokines", Biochem. Biophys. Res. Commun, 401, pp.7~12 (2010)
- Garrett WS, "Homeostasis and inflammation in the intestine", Cell, 140, pp.859~870 (2010)
- Aich P, "Comparative analysis of innate immune responses following infection of newborn calves with bovine rotavirus and bovine coronavirus", J. Gen. Virol, 88, pp.2749~2761 (2007)
- Crystal RG, "Future research directions in idiopathic pulmonary fibrosis : summary of a national heart, lung, and blood institute working group", Am. J. Respir. Crit. Care Med, 166, pp.236~246 (2002)
- Gordon S, "Alternative activation of macrophages : mechanism and functions", Immunity, 32, pp.593~604 (2010)
- 엄요한, "Viperin Deficiency Promotes Polarization of Macrophages and Secretion of M1 and M2 Cytokines", Immune Network, 18(4), pp.1~12 (2018), 대한면역학회[DOI]
- Braga TT, "Macrophages during the fibrotic process : M2 as friend and foe", Front. Immunol, 6, pp.602~ (2015)
- Conway B, "Cellular orchestrators of renal fibrosis", QJM, 105, pp.611~615 (2012)